内皮损伤在移植物抗宿主病发生发展中作用的研究进展

doi:10.16352/j.issn.1001-6325.2023.11.1728

基础医学与临床 ›› 2023, Vol. 43 ›› Issue (11): 1728-1732.doi: 10.16352/j.issn.1001-6325.2023.11.1728

内皮损伤在移植物抗宿主病发生发展中作用的研究进展

陆文琪, 万琳^*

苏州大学附属儿童医院国家血液系统疾病临床医学研究中心,江苏苏州 215127

收稿日期:2023-02-07 修回日期:2023-05-30 出版日期:2023-11-05 发布日期:2023-10-30
通讯作者: ^*lynnwanlin@hotmail.com
基金资助:
国家自然科学基金(81800185)

Research progress of endothelial injury in the development of graft-versus-host disease

LU Wenqi, WAN Lin^*

National Clinical Research Center for Hematologic Diseases, Children's Hospital of Soochow University, Suzhou 215127, China

Received:2023-02-07 Revised:2023-05-30 Online:2023-11-05 Published:2023-10-30
Contact: ^*lynnwanlin@hotmail.com

摘要/Abstract

摘要： 移植物抗宿主病 (GVHD) 是异基因造血干细胞移植(allo-HSCT)后严重的并发症之一。免疫介导的血管内皮损伤是GVHD的重要环节。Allo-HSCT前在放化疗以及感染等因素造成内皮损伤的基础上,供者T细胞与受者受损内皮细胞抗原直接接触,分泌细胞因子和炎性介质杀伤内皮细胞,炎性细胞浸润,导致内皮细胞进一步凋亡及耗竭,加剧靶器官的功能损害及全身多系统损伤。探索GVHD的内皮损伤机制,为GVHD的预防和治疗提供新思路。

关键词: 异基因造血干细胞移植, 移植物抗宿主病, 内皮损伤

Abstract: Graft-versus-host disease (GVHD) is one of the most serious complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT), resulting a very high mortality risk and no effective diagnosis and treatment method. Although an increasing number of studies suggest that immune-mediated vascular endothelial damage plays an important role in GVHD, the specific mechanism remains elusive. On the basis of endothelial injury caused by radiotherapy and chemotherapy before allo-HSCT and infection, the donor T cells directly contact with the damaged endothelial cell antigen, secrete cytokines and inflammatory mediators to kill endothelial cells, leading to further apoptosis and depletion of endothelial cells, and exacerbating the functional damage of target organs and multi-system injury of the body. To explore the endothelial injury mechanism of GVHD. This review provides a new idea for the prevention and treatment of GVHD.

Key words: allogeneic hematopoietic stem cell transplantation, graft-versus-host disease, endothelial injury

中图分类号:

R392.4

陆文琪, 万琳. 内皮损伤在移植物抗宿主病发生发展中作用的研究进展[J]. 基础医学与临床, 2023, 43(11): 1728-1732.

LU Wenqi, WAN Lin. Research progress of endothelial injury in the development of graft-versus-host disease[J]. Basic & Clinical Medicine, 2023, 43(11): 1728-1732.

0
/ / 推荐

导出引用管理器 EndNote|Reference Manager|ProCite|BibTeX|RefWorks

链接本文: http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/10.16352/j.issn.1001-6325.2023.11.1728

http://journal11.magtechjournal.com/Jwk_jcyxylc/CN/Y2023/V43/I11/1728

参考文献

[1]McDonald GB, Sandmaier BM, Mielcarek M, et al. Survival, nonrelapse mortality, and relapse-related mortality after allogeneic hematopoietic cell transplantation: comparing 2003—2007 versus 2013—2017 cohorts[J]. Ann Intern Med, 2020, 172:229-239.
[2]Haji S, Shiratsuchi M, Takamatsu A, et al. Endothelial function testing before conditioning therapy is useful for predicting transplant-related complications after allogeneic hematopoietic cell transplantation[J]. Int J Hematol, 2023, 117:438-445.
[3]Boittin FX, Beddek K, Thery H, et al. The immunosuppressant drug cyclosporin A aggravates irradiation effects in endothelial cells[J]. Biochem Biophys Res Commun, 2022, 602:127-134.
[4]Mulder K, Patel AA, Kong WT, et al. Cross-tissue single-cell landscape of human monocytes and macrophages in health and disease[J]. Immunity, 2021, 54:1883-1900.
[5]Yalcin K, Pehlivan B, Celen S, et al. Comparison of total Body irradiation-based versus chemotherapy-based conditionings for early complications of allogeneic hematopoietic stem cell transplantation in children with ALL[J]. J Pediatr Hematol Oncol, 2021, 43:266-270.
[6]Link-Rachner CS, Sockel K, Schuetz C. Established and emerging treatments of skin GvHD[J]. Frontiers Immunol Vol, 2022,13:838494.doi:10.3389/fimmu.2022.838494.
[7]Deschaumes C, Verneuil L, Ertault-Daneshpouy M, et al. CD95 ligand-dependant endothelial cell death initiates oral mucosa damage in a murine model of acute graft versus host disease[J]. Lab Invest, 2007, 87: 417-429.
[8]Zouali H, Lemasson J, Calugareanu A, et al. RNA sequencing of chronic GVHD skin lesions defines shared and unique inflammatory pathways characterizing lichen planus and morphea[J]. Blood Adv, 2022, 6:2805-2811.
[9]Lopes PDD, de Assis N, de Araújo NF, et al. COX/iNOS dependence for angiotensin-Ⅱ-induced endothelial dysfunction[J]. Peptides, 2022, 157:170863. doi:10.1016/j.peptides.2022.170863.
[10]Ogasawara R, Hashimoto D, Kimura S, et al. Intestinal lymphatic endothelial cells produce R-spondin3[J]. Sci Rep, 2018, 8: 10719. doi:10.1038/s41598-018-29100-7.
[11]Mertlitz S, Shi Y, Kalupa M, et al. Lymphangiogenesis is a feature of acute GVHD, and VEGFR-3 inhibition pro-tects against experimental GVHD[J]. Blood, 2017, 129: 1865-1875.
[12]Gloude NJ, Khandelwal P, Luebbering N, et al. Circulating dsDNA, endothelial injury, and complement activation in thrombotic microangiopathy and GVHD[J]. Blood, 2017, 130: 1259-1266.
[13]Qi J, Pan T, You T. Upregulation of HIF-1α contributes to complement activation in transplantation-associated thrombotic microangiopathy[J]. Br J Haematol, 2022, 199: 603-615.
[14]Özkan HA, Özkan SG. Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation in adult patients: diagnosis, incidence, prophylaxis, and treatment[J]. Transfus Apher Sci, 2022, 61:103372. doi: 10.1016/j.transci.2022.103372.
[15]Pereira M, Lee NT, Noonan J. Early endothelial activa-tion in a mouse model of graft vs host disease following chemotherapy[J]. Front Immunol, 2021, 12: 708554. doi: 10.3389/fimmu.2021.708554.
[16]Cordes S, Mokhtari Z, Bartosova M. Endothelial damage and dysfunction in acute graft-versus-host disease[J]. Haematologica, 2021, 106: 2147-2160.
[17]Gavriilaki E, Sakellari I, Anyfanti P, et al. Assessment of endothelial injury and pro-coagulant activity using circulating microvesicles in survivors of allogeneic hematopoietic cell transplantation[J]. Int J Mol Sci, 2020, 21:9768. doi:10.3390/ijms21249768.
[18]Mathew NR, Vinnakota JM, Apostolova P, et al. Graft-versus-host disease of the CNS is mediated by TNF upregulation in microglia[J]. J Clin Invest, 2020, 130: 1315-1329.
[19]Bonelli F, Lasagni Vitar RM, Merlo Pich FG, et al. Corneal endothelial cell reduction and increased neurokinin-1 receptor expression in a graft-versus-host disease preclini-cal model[J]. Exp Eye Res, 2022, 220:109128. doi:10.1016/j.exer.2022.109128.
[20]Ranjan S, Goihl A, Kohli S, et al. Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells[J]. Nat Commun, 2017, 8:311. doi:10.1038/s41467-017-00169-4.
[21]Dorrance AM, Moutuou MM, Goda C, et al. Modulating endothelial cells with EGFL7 to diminish aGVHD after allogeneic bone marrow transplantation in mice[J]. Blood Adv, 2022, 6: 2403-2408.
[22]García-Bernal D, Palomo M, Martínez CM, et al. Defibrotide inhibits donor leucocyte-endothelial interactions and protects against acute graft-versus-host disease[J]. J Cell Mol Med, 2020, 24: 8031-8044.
[23]Zhao K, Tian Y, Wang J, et al. Fluvastatin-pretreated donor cells attenuated murine aGVHD by balancing effector T cell distribution and function under the regula-tion of KLF2[J]. Biomed Res Int, 2020, 2020:7619849. doi:10.1155/2020/7619849.
[24]Bézie S, Charreau B, Vimond N, et al. Human CD8⁺ Tregs expressing a MHC-specific CAR display enhanced suppression of human skin rejection and GVHD in NSG mice[J]. Blood Adv, 2019, 3: 3522-3538.
[25]Wang W, Ye Y, Du Y, et al. EPC infusion ameliorates acute graft-versus-host disease-related endothelial injury after allogeneic bone marrow transplantation[J]. Front Immunol, 2022, 13:1019657. doi:10.3389/fimmu.2022.1019657.

内皮损伤在移植物抗宿主病发生发展中作用的研究进展

Research progress of endothelial injury in the development of graft-versus-host disease

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 3

编辑推荐

Metrics

本文评价

[1]	邹洁, 张德德, 陶毅, 赵静, 王琼, 徐乃佳. 葛根素减轻KKAy小鼠血管内皮细胞炎性反应[J]. 基础医学与临床, 2023, 43(3): 433-437.
[2]	武坤, 聂波, 李云涛, 杨金荣, 程沈菊, 李艳红, 史明霞. 外周血miR-200c水平对移植异基因造血干细胞后急性移植物抗宿主病发生的预测作用[J]. 基础医学与临床, 2022, 42(6): 871-875.
[3]	房婷, 李响, 刘洁, 王皓. 鼠李糖乳杆菌通过调节肠道微生物群缓解造血干细胞移植后肝脏移植物抗宿主病[J]. 基础医学与临床, 2021, 41(9): 1303-1308.